DYNAMIC PRICING AND PRODUCT/PROCESS R&D WITH REFERENCE QUALITY EFFECT IN A MONOPOLY

被引:0
|
作者
Ge, Lijia [1 ]
Li, Shoude [1 ]
机构
[1] Shanghai Jiao Tong Univ, Antai Coll Econ & Management, Shanghai 200052, Peoples R China
关键词
Product and process R&D; reference quality; pricing; dynamic optimal control; non-linear system; PRODUCT QUALITY; INNOVATION; SIGNALS; PRICES; MODEL; PORTFOLIO; CHOICE;
D O I
10.3934/jimo.2022248
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
In this article, we construct a dynamic optimal control model where the price and R&D portfolio are simultaneously determined by a monopolist with the consumers' reference effect about product quality. We extend the conventional model by describing the product and process R&D with non-linear dynamic equations and considering the signal effect of price on the change rate of reference quality. Our analysis mainly suggests that: (i) the non-linear system admits at most two steady-state saddle-point equilibria under both monopoly and social planning; (ii) the product price is increasing (decreasing) in the effort for quality improvement in the beginning (ending) period of the time horizon, while the price is always decreasing in the effort for marginal production cost reduction; (iii) in the neighbourhood of consumers' memory parameter, the two dimensions of R&D portfolio are substitutes (complements) if and only if the signal effect of the price is strong (weak); (iv) the change rates of the efforts in product and process R&D are increasing (decreasing) in memory parameter if and only if the signal effect of the price is below (above) some threshold; (v) by examining the extreme case of key parameters, we find that the system cannot converge to the steady-state equilibrium when consumers' adjustment speed about reference quality is low under both monopoly and social planning.
引用
收藏
页码:6989 / 7017
页数:29
相关论文
共 50 条
  • [41] Unique collaborative R&D product
    不详
    [J]. AUSTRALASIAN BIOTECHNOLOGY, 1998, 8 (06) : 345 - 345
  • [42] R&D Collaborations and Product Innovation
    Un, C. Annique
    Cuervo-Cazurra, Alvaro
    Asakawa, Kazuhiro
    [J]. JOURNAL OF PRODUCT INNOVATION MANAGEMENT, 2010, 27 (05) : 673 - 689
  • [43] R&D WITH SPILLOVERS: MONOPOLY VERSUS NONCOOPERATIVE AND COOPERATIVE DUOPOLY
    Stepanova, Anna
    Tesoriere, Antonio
    [J]. MANCHESTER SCHOOL, 2011, 79 (01): : 125 - 144
  • [44] Monopoly capital and innovation: an exploratory assessment of R&D effectiveness
    Lambert, Thomas E.
    [J]. INTERNATIONAL REVIEW OF APPLIED ECONOMICS, 2020, 34 (01) : 36 - 49
  • [45] Tying Medicare Part B Drug Prices to International Reference Pricing Will Devastate R&D
    Duane Schulthess
    Daniel Gassull
    Steven Maisel
    [J]. Therapeutic Innovation & Regulatory Science, 2019, 53 : 746 - 751
  • [46] Tying Medicare Part B Drug Prices to International Reference Pricing Will Devastate R&D
    Schulthess, Duane
    Gassull, Daniel
    Maisel, Steven
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2019, 53 (06) : 746 - 751
  • [47] Grey in the R&D Process
    Jeffery, Keith G.
    Asserson, Anne
    [J]. SEVENTH INTERNATIONAL CONFERENCE ON GREY LITERATURE, GL7 CONFERENCE PROCEEDINGS: OPEN ACCESS TO GREY RESOURCES, 2006, (07): : 22 - +
  • [48] Women in Process R&D
    Laird, Trevor
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2013, 17 (10) : 1220 - 1220
  • [49] Quality improvement and pricing with reference quality effect
    Xue, Musen
    Zhang, Jianxiong
    Tang, Wansheng
    Dai, Rui
    [J]. JOURNAL OF SYSTEMS SCIENCE AND SYSTEMS ENGINEERING, 2017, 26 (05) : 665 - 682
  • [50] Quality improvement and pricing with reference quality effect
    Musen Xue
    Jianxiong Zhang
    Wansheng Tang
    Rui Dai
    [J]. Journal of Systems Science and Systems Engineering, 2017, 26 : 665 - 682